Framingham, MA, United States of America

Martin Tolar

This inventor holds 9 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 9 EPO patents. Top assignee: Alzheon, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Tolar. Retrieved from https://idiyas.com/inventor/martin-tolar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Martin Tolar: Innovator in Neurodegenerative Disorder Treatments

Introduction

Martin Tolar is a prominent inventor based in Framingham, MA (US), known for his significant contributions to the field of neurodegenerative disorders. With a total of nine patents to his name, Tolar has made remarkable strides in developing treatments for conditions such as Alzheimer's disease.

Latest Patents

Among his latest patents, Tolar has focused on sulfopropanoic acid derivatives for treating neurodegenerative disorders. His work includes the use of a compound of Formula (I) and the development of compositions and methods aimed at treating and preventing neurodegenerative diseases. These innovations are crucial in the ongoing battle against Alzheimer's disease, providing new avenues for therapeutic intervention.

Career Highlights

Tolar's career is marked by his role at Alzheon, Inc., where he has been instrumental in advancing research and development in the pharmaceutical sector. His expertise and dedication have positioned him as a key figure in the fight against neurodegenerative disorders.

Collaborations

Some of his notable coworkers include John A. Hey and Petr Kocis, who have collaborated with Tolar on various projects aimed at enhancing the understanding and treatment of neurodegenerative diseases.

Conclusion

Martin Tolar's innovative work and dedication to treating neurodegenerative disorders have made a significant impact in the field. His contributions continue to pave the way for new treatments and hope for those affected by these challenging conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…